Cancer survival rates
Pro Research Analysisby 
Searched over 200M research papers
Global Cancer Survival Rates: Trends and Regional Differences
Cancer survival rates have improved worldwide over recent decades, but there are still significant differences between countries, cancer types, and patient groups. Survival rates are a key measure of the effectiveness of health systems and cancer control strategies, and they vary based on early detection, treatment advances, and access to care .
Five-Year Survival Rates by Country and Cancer Type
The five-year relative survival rate for all cancers combined is about 62.7% in the United States, with higher rates for cancers like prostate, female breast, corpus uteri, and urinary bladder (over 75% at eight years) . In Korea, the five-year relative survival rate for all cancers diagnosed between 2013 and 2017 was 70.4% . In China, the five-year relative survival rate for all cancers was much lower at 30.9%, with significant urban-rural disparities (39.5% in urban areas vs. 21.8% in rural areas) .
Globally, countries like the USA, Canada, Australia, New Zealand, and Nordic countries have some of the highest five-year survival rates for most cancers. For example, five-year survival for breast cancer is 90.2% in the USA and 89.5% in Australia, but only 66.1% in India . For gastrointestinal cancers, South Korea and Japan report some of the highest survival rates, such as 68.9% for stomach cancer and 71.8% for colon cancer in South Korea .
Improvements Over Time and Factors Affecting Survival
Cancer survival rates have generally increased over time due to advances in early detection and treatment 257. For example, five-year survival for distant-stage female breast cancer in the US increased from 18.7% in the late 1970s to 33.6% in the early 2010s . Long-term survival rates (10, 15, and 20 years) have also improved, especially for cancers like thyroid, testis, melanoma, prostate, and endometrial cancer .
However, progress is not uniform across all cancer types. Survival rates for liver, pancreas, and brain cancers remain low, and improvements have been limited 24. Survival also varies by age, with older patients generally having poorer outcomes .
Importance of Early Diagnosis and Stage at Detection
Early diagnosis is critical for improving cancer survival. Survival rates are much higher when cancer is detected at an early stage. For most cancers, one- and five-year survival is significantly better for stage 1 diagnoses compared to later stages . For example, prostate cancer has very high one-year survival rates regardless of stage, but five-year survival drops sharply if detected at stage 4 .
Disparities in Survival: Socioeconomic, Geographic, and Racial Factors
Significant disparities in cancer survival exist based on race, ethnicity, and geography. In the US, the risk of death from cancer is 33% higher in non-Hispanic Blacks and 51% higher in non-Hispanic American Indian/Alaska Natives compared to non-Hispanic Whites . In China, urban patients have nearly double the survival rate of rural patients . In Europe, five-year childhood cancer survival ranges from 70% to 82% depending on the country, with lower rates in Eastern Europe due to limited healthcare resources .
Survival Rates in Specific Cancers
- Colorectal Cancer: Five-year survival rates have improved globally, with the highest rates in Korea, Japan, Australia, and the USA. Survival is generally lower in older patients and varies by sex and region .
- Childhood Cancers: In Europe, five-year survival for childhood cancers diagnosed in 2000–2007 was 77.9%, with improvements over time but persistent regional disparities .
- Lung and Liver Cancer: These cancers continue to have poor survival rates worldwide, with only modest improvements in some countries 234.
Conclusion
Cancer survival rates are improving globally, especially in high-income countries and for cancers that benefit from early detection and effective treatment. However, large disparities remain between countries, regions, and patient groups. Early diagnosis, equitable access to care, and continued investment in cancer control are essential to further improve survival outcomes and reduce inequalities 1234+5 MORE.
Sources and full results
Most relevant research papers on this topic